Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 161

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Alpha‐1‐antitrypsin inhibits human immunodeficiency virus type 1

SHAPIRO, LELAND, B. POTT, GREGORY, H. RALSTON, ANNEMARIE·2001·The FASEB Journal

Abstract

Several observations suggest the existence of potent endogenous suppressors of human immunodeficiency virus type 1 (HIV‐1) production, and inhibitors of serine proteases may participate in this effect. Alpha‐1‐antitrypsin (AAT) is the most abundant circulating serine protease inhibitor. Physiological AAT concentrations inhibited HIV‐1 production in chronically infected U1 monocytic cells, reduced virus replication in freshly infected peripheral blood mononuclear cells, and blocked infection of permissive HeLa cells. In U1 cells, AAT suppressed activation of the HIV‐1‐inducing transcription factor NF‐κB. Similar results were obtained using CE‐2072, a synthetic inhibitor of host serine proteases. HIV‐1 did not replicate in blood obtained from healthy volunteers, but marked replication was observed in blood from individuals with hereditary AAT deficiency. These results identify AAT as a candidate circulating HIV‐1 inhibitor in vivo. Two different mechanisms of AAT‐induced HIV‐1 inhibition were identified, including reduced HIV‐1 infectivity and blockade of HIV‐1 production. A novel host pathogen interaction is suggested, and an alternative strategy to treat HIV‐1‐related disease may be possible.—Shapiro, L., Pott, G. B., Ralston, A. H. Alpha‐1‐antitrypsin inhibits human immunodeficiency virus type 1. FASEB J. 15, 122–115 (2001)

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.00-0311com

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 161

Metadata

Authors
SHAPIRO, L., B. POTT, G., & H. RALSTON, A.
Venue
The FASEB Journal
Publisher
Wiley
Published
2001-01
Volume
15
Issue
1
Pages
115-122
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2087018289
Cited by
161
References
1
FWCI
1.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alpha‐1‐antitrypsin inhibits human immunodeficiency virus type 1. https://app.cochat.ai/papers/10.1096/fj.00-0311com
The paper
SHAPIRO, L., B. POTT, G., & H. RALSTON, A. (2001). Alpha‐1‐antitrypsin inhibits human immunodeficiency virus type 1. The FASEB Journal. https://doi.org/10.1096/fj.00-0311com

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.